<DOC>
	<DOCNO>NCT02328521</DOCNO>
	<brief_summary>The investigator aim investigate effect oral nicorandil neointima coronary drug-eluting stent implantation patient diabetic mellitus .</brief_summary>
	<brief_title>Efficacy Study Nicorandil Neointima</brief_title>
	<detailed_description>In era bare metal stent ( BMS ) , restenosis rate 25 % . The introduction drug-eluting stent ( DES ) reduce restenosis rate 4 % -10 % . Neointimal hyperplasia restenosis remain problem DES implantation . Besides , DES cause increase uncovered strut , late stent thrombosis , neoatherosclerosis , heterogeneous neointima . Diabetes mellitus ( DM ) result increase risk atherosclerosis , in-stent restenosis , neoatherosclerosis late-stent thrombosis . Nicorandil , hybrid adenosine triphosphate-sensitive potassium ( K-ATP ) channel opener nitrate , show reduce target vessel revascularization stent implantation , target lesion revascularization rotational atherectomy , restenosis patient undergo percutaneous coronary intervention ( PCI ) . Intracoronary optical coherence tomography ( OCT ) emerge high-resolution imaging method analysis neointima grow stent . We aim examine effect nicorandil neointima coronary DES implantation patient unstable angina DM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Neointima</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>unstable angina diabetes mellitus give glibenclamide clinical indication percutaneous coronary intervention de novo severe stenosis native coronary artery lesion suitable stent optical coherence tomography examination reference vessel size 2.5 4.0mm drugeluting stent implantation acute myocardial infarction within 2 week percutaneous coronary intervention contraindication treatment nicorandil ( allergy , glaucoma , digestive ulcer , currently take phosphodiesterase5 inhibitor ) bypass restenosis PCI history hypotension intolerance platelet inhibitor statins impaired liver function renal insufficiency require hemodialysis pregnancy connective tissue disease life expectancy â‰¤ 12 month leave main coronary artery disease bypass graft lesion lesion unsuitable OCT unwillingness inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Neointima</keyword>
	<keyword>Tomography , Optical Coherence</keyword>
	<keyword>drug-eluting stent</keyword>
	<keyword>Nicorandil</keyword>
</DOC>